Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

EGFR as a target: rationale for therapy.

Debra Wujcik1

  • 1Vanderbilt-Ingram Cancer Center, Clinical Trials Office, 9th Floor, 1818 Albion Street, Nashville, TN 37208, USA. debbie.wujcik@vanderbilt.edu

Seminars in Oncology Nursing
|April 18, 2006
PubMed
Summary

The epidermal growth factor receptor (EGFR) is crucial in normal physiology and cancer. Targeting EGFR with new therapies offers a significant advancement in treating solid tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel programs to improve patient access and understanding of Medications: Nashville General Hospital Pharmacy Services.

Journal of the American Pharmacists Association : JAPhA·2025
Same author

Remote Symptom Alerts and Patient-Reported Outcomes (PROS) in Real-World Breast Cancer Practice: Innovative Data to Derive Symptom Burden and Quality of Life.

Bioengineering (Basel, Switzerland)·2024
Same author

Integrating electronic geriatric assessment and frailty screening for adults with acute myeloid leukemia to drive personalized treatment decisions.

Leukemia research·2023
Same author

Goals, preferences, and concerns of patients with acute myeloid leukemia at time of treatment decision.

Journal of geriatric oncology·2023
Same author

A Study Design to Harmonize Patient-Reported Outcomes Across Data Sets.

JCO clinical cancer informatics·2023
Same author

Electronic Patient Symptom Management Program to Support Patients Receiving Cancer Treatment at Home During the COVID-19 Pandemic.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2022

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The epidermal growth factor receptor (EGFR) plays a vital role in cellular functions.
  • Dysregulation of EGFR signaling is implicated in various cancers.
  • Understanding EGFR biology is key to developing targeted cancer therapies.

Purpose of the Study:

  • To review the biology, structure, and signaling pathways of EGFR.
  • To outline EGFR's role in normal physiology and cancer development.
  • To discuss current anti-EGFR therapeutic strategies.

Main Methods:

  • Literature review of research articles.

Main Results:

  • EGFR is overexpressed in several tumor types.
  • EGFR abnormalities contribute to carcinogenesis and tumor progression.
  • Anti-EGFR therapies represent a significant therapeutic advance.

Conclusions:

  • EGFR is a validated therapeutic target for solid tumors.
  • Current anti-EGFR therapies are clinically available.
  • Enhanced understanding of EGFR is beneficial for cancer care professionals.

Related Experiment Videos